A detailed history of Morgan Stanley transactions in Landec Corp \Ca\ stock. As of the latest transaction made, Morgan Stanley holds 776,690 shares of LNDC stock, worth $0. This represents 0.0% of its overall portfolio holdings.

Number of Shares
776,690
Previous 746,234 4.08%
Holding current value
$0
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
N/A
30,456 Added 4.08%
776,690 $0
Q2 2024

Oct 17, 2024

SELL
N/A
-45,573 Reduced 5.76%
746,234 $0
Q2 2024

Aug 14, 2024

SELL
N/A
-45,573 Reduced 5.76%
746,234 $0
Q1 2024

Oct 17, 2024

BUY
N/A
45,573 Added 6.11%
791,807 $0
Q1 2024

Aug 16, 2024

BUY
N/A
3,105 Added 0.39%
791,807 $0
Q1 2024

May 15, 2024

BUY
N/A
3,105 Added 0.39%
791,807 $0
Q4 2023

Aug 16, 2024

BUY
N/A
42,468 Added 5.69%
788,702 $0
Q4 2023

Feb 13, 2024

SELL
N/A
-6,239 Reduced 0.78%
788,702 $0
Q3 2023

Nov 15, 2023

SELL
N/A
-22,553 Reduced 2.76%
794,941 $0
Q2 2023

Aug 14, 2023

SELL
N/A
-51,606 Reduced 5.94%
817,494 $0
Q1 2023

May 15, 2023

BUY
N/A
229,501 Added 35.88%
869,100 $0
Q4 2022

Feb 14, 2023

BUY
$0.0 - $9.95 $0 - $244,391
24,562 Added 3.99%
639,599 $0
Q3 2022

Nov 14, 2022

BUY
$8.57 - $11.57 $53,528 - $72,266
6,246 Added 1.03%
615,037 $5.47 Million
Q2 2022

Oct 27, 2022

BUY
$8.84 - $11.64 $167,173 - $220,124
18,911 Added 3.21%
608,791 $6.07 Million
Q2 2022

Aug 15, 2022

BUY
$8.84 - $11.64 $167,173 - $220,124
18,911 Added 3.21%
608,791 $6.07 Million
Q1 2022

Oct 27, 2022

SELL
$10.07 - $11.93 $190,433 - $225,608
-18,911 Reduced 3.11%
589,880 $6.83 Million
Q1 2022

May 13, 2022

SELL
$10.07 - $11.93 $119,802 - $141,931
-11,897 Reduced 1.98%
589,880 $6.83 Million
Q4 2021

Feb 14, 2022

BUY
$7.95 - $11.24 $84,047 - $118,829
10,572 Added 1.79%
601,777 $6.68 Million
Q3 2021

Nov 15, 2021

BUY
$9.22 - $12.44 $5.45 Million - $7.35 Million
591,205 New
591,205 $5.45 Million

Others Institutions Holding LNDC

About LANDEC CORP \CA\


  • Ticker LNDC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 29,595,600
  • Description
  • Landec Corporation operates as a diversified health and wellness company. The company manufactures pharmaceutical-grade sodium hyaluronate (HA)-based biomaterials for primary use in the ophthalmic and orthopedic markets. It also provides product development services to its partners for HA-based, as well as non-HA based, aseptically formulated, a...
More about LNDC
Track This Portfolio

Track Morgan Stanley Portfolio

Follow Morgan Stanley and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.